Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immuno-oncology
immuno-oncology
NextCure Delays 2 Clinical Trials Due to Coronavirus
Motley Fool
Tue, 04/14/20 - 09:57 pm
NextCure
clinical trials
COVID-19
pandemic
immuno-oncology
NC318
NC410
Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout?
Investors Business Daily
Sat, 03/7/20 - 07:41 pm
Gilead Scinecs
M&A
Forty Seven
immuno-oncology
Could immuno-oncology treatments get a boost from a 64-year-old antipsychotic?
Fierce Biotech
Fri, 03/6/20 - 10:52 am
cancer
immuno-oncology
prochlorperazine
antipsychotics
drug repurposing
Iovance shares jump on buyout rumors
Fierce Biotech
Wed, 02/26/20 - 10:40 am
immuno-oncology
Iovance
M&A
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Tue, 02/25/20 - 10:18 am
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
Roche’s next immuno-oncology combo is a big bet on Tigit
EP Vantage
Fri, 01/31/20 - 10:47 am
Roche
immuno-oncology
Tigit
Merck-partnered biotech hands Roche its half-life extension tech as it pivots to immuno-oncology
Endpoints
Fri, 01/10/20 - 10:21 am
Roche
immuno-oncology
Amunix
Merck
CAR-T
Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning
Motley Fool
Sun, 12/15/19 - 12:15 am
Sanofi
M&A
immuno-oncology
Lantus
diabetes
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Thu, 12/12/19 - 11:12 am
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer
Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both
Motley Fool
Tue, 12/10/19 - 11:48 pm
Sanofi
immuno-oncology
M&A
Synthorx
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Endpoints
Thu, 11/21/19 - 10:21 am
Novartis
Bayer
Longwood
immunotherapy
genomics
immuno-oncology
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Fierce Biotech
Mon, 11/11/19 - 10:44 am
Bolt Biotherapeutics
immuno-oncology
clinical trials
cancer
Early data on NextCure's immuno-oncology drug in lung cancer patients delights investors
Endpoints
Thu, 11/7/19 - 10:18 am
NextCure
immuno-oncology
NC318
Regeneron defends bid to challenge Merck in lung cancer
Biopharma Dive
Tue, 11/5/19 - 11:45 pm
Regeneron
Libtayo
Merck
Keytruda
immuno-oncology
lung cancer
Working on the Next Generation of Immuno-Oncology Therapies
BioSpace
Fri, 10/25/19 - 10:42 am
immuno-oncology
immunotherapy
Washington University School of Medicine
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Fierce Pharma
Mon, 10/21/19 - 04:36 pm
Roche
liver cancer
Tecentriq
immuno-oncology
Avastin
Nexavar
Merck, Pfizer execs explain how they tap sites for cancer trials
Biopharma Dive
Tue, 09/24/19 - 07:04 pm
cancer
clinical trials
Pfizer
Merck
immuno-oncology
Bavencio
Keytruda
Cancer centers stretching to keep up with pharma's oncology interest
Biopharma Dive
Mon, 09/23/19 - 07:47 pm
oncology
cancer
immuno-oncology
clinical trials
cancer centers
R&D
Stopping the spread of pancreatic cancer
Fierce Biotech
Mon, 08/12/19 - 10:38 am
pancreatic cancer
immuno-oncology
Bayer-backed Pyxis debuts with $22M to pursue new immuno-oncology targets
BioCentury
Wed, 07/17/19 - 11:06 pm
Pyxis
Bayer
immuno-oncology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »